Huadong Medicine Co Ltd
SZSE:000963
Wall Street
Price Targets
Price Targets Summary
Huadong Medicine Co Ltd
According to Wall Street analysts, the average 1-year price target for Huadong Medicine Co Ltd is 47.09 CNY with a low forecast of 40.4 CNY and a high forecast of 62.84 CNY.
Operating Income
Forecast
Operating Income Estimate
Huadong Medicine Co Ltd
For the last 8 years the compound annual growth rate for Huadong Medicine Co Ltd's operating income is 12%. The projected CAGR for the next 4 years is 26%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Huadong Medicine Co Ltd's stock price target?
Price Target
47.09
CNY
According to Wall Street analysts, the average 1-year price target for Huadong Medicine Co Ltd is 47.09 CNY with a low forecast of 40.4 CNY and a high forecast of 62.84 CNY.
What is Huadong Medicine Co Ltd's Revenue forecast?
Projected CAGR
11%
For the last 8 years the compound annual growth rate for Huadong Medicine Co Ltd's revenue is 9%. The projected CAGR for the next 4 years is 11%.
What is Huadong Medicine Co Ltd's Operating Income forecast?
Projected CAGR
26%
For the last 8 years the compound annual growth rate for Huadong Medicine Co Ltd's operating income is 12%. The projected CAGR for the next 4 years is 26%.
What is Huadong Medicine Co Ltd's Net Income forecast?
Projected CAGR
28%
For the last 8 years the compound annual growth rate for Huadong Medicine Co Ltd's net income is 16%. The projected CAGR for the next 4 years is 28%.